Previous close | 13.27 |
Open | 14.37 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 680.00 |
Expiry date | 2024-08-16 |
Day's range | 13.27 - 14.37 |
Contract range | N/A |
Volume | |
Open interest | N/A |
The Dow, S&P 500 and Nasdaq hit record highs on tame inflation data. Nvidia broke out, leading new buys.
Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.
Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.